Skip to content
10-Q

Quarterly Report

AVITA MEDICAL, INC. AVHHL RCEL

0001762303-25-000014

← back to feed
Filed
Aug 8, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Aug 4, 2025 26.62M sh
Shares Diluted Q2 2025 · Jun 30, 2025 26.37M sh
Shares Diluted Q2 2025 · Jun 30, 2025 26.4M sh
Shares Diluted Q2 2025 · Jun 30, 2024 25.76M sh
Shares Diluted Q2 2025 · Jun 30, 2024 25.7M sh
Capex Q2 2025 · Jun 30, 2025 $745K
Capex Q2 2025 · Jun 30, 2024 $3.8M
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$20.54M
Operating Cash Flow Q2 2025 · Jun 30, 2024 −$33.64M
Long Term Debt Q2 2025 · Jun 30, 2025 $42.22M
Long Term Debt Q2 2025 · Dec 31, 2024 $0
Cash And Equivalents Q2 2025 · Jun 30, 2025 $12.22M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $14.05M
Stockholders Equity Q2 2025 · Jun 30, 2025 −$12.89M
Stockholders Equity Q2 2025 · Mar 31, 2025 −$4.57M
Stockholders Equity Q2 2025 · Dec 31, 2024 $4.5M
Stockholders Equity Q2 2025 · Jun 30, 2024 $23.92M
Stockholders Equity Q2 2025 · Mar 31, 2024 $32.57M
Stockholders Equity Q2 2025 · Dec 31, 2023 $49.06M
Current Liabilities Q2 2025 · Jun 30, 2025 $62.6M
Current Liabilities Q2 2025 · Dec 31, 2024 $20.16M
Total Liabilities Q2 2025 · Jun 30, 2025 $70.98M
Total Liabilities Q2 2025 · Dec 31, 2024 $74.97M
Current Assets Q2 2025 · Jun 30, 2025 $36.25M
Current Assets Q2 2025 · Dec 31, 2024 $57M
Total Assets Q2 2025 · Jun 30, 2025 $58.13M
Total Assets Q2 2025 · Dec 31, 2024 $79.71M
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.38
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.90
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.60
Eps Diluted Q2 2025 · Jun 30, 2024 −$1.32
Eps Basic Q2 2025 · Jun 30, 2025 −$0.38
Eps Basic Q2 2025 · Jun 30, 2025 −$0.90
Eps Basic Q2 2025 · Jun 30, 2024 −$0.60
Eps Basic Q2 2025 · Jun 30, 2024 −$1.32
Sga Expense Q2 2025 · Jun 30, 2025 $6.67M
Sga Expense Q2 2025 · Jun 30, 2025 $13.06M
Sga Expense Q2 2025 · Jun 30, 2024 $7.52M
Sga Expense Q2 2025 · Jun 30, 2024 $16.48M
Rd Expense Q2 2025 · Jun 30, 2025 $5.12M
Rd Expense Q2 2025 · Jun 30, 2025 $11.4M
Rd Expense Q2 2025 · Jun 30, 2024 $4.89M
Rd Expense Q2 2025 · Jun 30, 2024 $10.08M
Net Income Q2 2025 · Jun 30, 2025 −$9.92M
Net Income Q2 2025 · Jun 30, 2025 −$23.78M
Net Income Q2 2025 · Jun 30, 2024 −$15.39M
Net Income Q2 2025 · Jun 30, 2024 −$34.05M
Operating Income Q2 2025 · Jun 30, 2025 −$11.15M
Operating Income Q2 2025 · Jun 30, 2025 −$22.98M
Operating Income Q2 2025 · Jun 30, 2024 −$15.62M
Operating Income Q2 2025 · Jun 30, 2024 −$32.83M
Gross Profit Q2 2025 · Jun 30, 2025 $14.95M
Gross Profit Q2 2025 · Jun 30, 2025 $30.63M
Gross Profit Q2 2025 · Jun 30, 2024 $13.08M
Gross Profit Q2 2025 · Jun 30, 2024 $22.68M
Cost Of Revenue Q2 2025 · Jun 30, 2025 $3.47M
Cost Of Revenue Q2 2025 · Jun 30, 2025 $6.3M
Cost Of Revenue Q2 2025 · Jun 30, 2024 $2.11M
Cost Of Revenue Q2 2025 · Jun 30, 2024 $3.62M
Revenue Q2 2025 · Jun 30, 2025 $18.42M
Revenue Q2 2025 · Jun 30, 2025 $36.93M
Revenue Q2 2025 · Jun 30, 2024 $15.2M
Revenue Q2 2025 · Jun 30, 2024 $26.3M